Puma Biotechnology (PBYI) Net Cash Flow (QoQ) (2012 - 2026)
Puma Biotechnology (PBYI) Net Cash Flow (QoQ) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Puma Biotechnology | 407.27 Mn | 368.99 Mn | 34.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 127.45% |
| Dec 31, 2025 | -2,001.14% |
| Sep 30, 2025 | 86.41% |
| Jun 30, 2025 | -35.21% |
| Mar 31, 2025 | -416.41% |
| Dec 31, 2024 | 1,615.79% |
| Sep 30, 2024 | 101.19% |
| Jun 30, 2024 | -22.57% |
| Mar 31, 2024 | -442.84% |
| Dec 31, 2023 | -89.51% |
| Sep 30, 2023 | 1,671.23% |
| Jun 30, 2023 | 90.63% |
| Mar 31, 2023 | -741.79% |
| Dec 31, 2022 | -106.98% |
| Sep 30, 2022 | 312.21% |
| Jun 30, 2022 | -47.21% |
| Mar 31, 2022 | -888.73% |
| Dec 31, 2021 | 96.85% |
| Sep 30, 2021 | -346.18% |
| Jun 30, 2021 | -156.03% |